Novel Human RNase 7 ELISA

Icosagen is pleased to announce the addition of a new product to its portfolio: a novel ELISA kit for quantitative detection of human RNase 7 in biological  fluids (urine, saliva, skin lavage etc.) and cell culture supernatant.
  • High sensitivity: Limit of detection 1-4 pg\ml 
  • High affinity: Can be used to detect very small quantities of hRNase 7 starting from 10 pg/mL  
  • The entire test procedure can be performed at room temperature: no 37°C incubator required 
  • Less steps: no avidin-biotin system – the enzyme conjugate binds directly to target antigen 
  • Short testing time: 2,5 h
RNase 7 ELISA kit datasheet as PDF.


Contact us 
We would appreciate the opportunity of collaborating with you.
Visit us at http://icosagen.com 
Write or call: sales@icosagen.com, phone: +372 737 7046

Kind regards, 
Icosagen team 
Icosagen is a biotech company providing custom production of recombinant proteins, antibodies, virus-like particles and a licensing platform (QMCF Technology) for protein production. Our customers are global pharmaceutical companies, the biotech industry and academic institutions around the world. Other activities include the development and sale of catalogue products, such as antibodies, proteins and ELISA kits. We also participate in several EU FP7 projects.
Icosagen was founded in 1999, as a spin-off company of the University of Tartu (Estonia).
Icosagen
Eerika tee 1, Õssu küla, Ülenurme vald
61713 Tartumaa, ESTONIA
Phone: +372 737 7070
E-mail: info@icosagen.com
www.icosagen.com